This Article Full Text Full Text (PDF) All Versions of this Article: 25/5/1026    most recent 01.ATV.0000160612.18065.29v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Veerkamp, M.J. Articles by Stalenhoef, A.F.H. Search for Related Content PubMed PubMed Citation Articles by Veerkamp, M.J. Articles by Stalenhoef, A.F.H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1026.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Role of Insulin Resistance in Familial Combined Hyperlipidemia

M.J. Veerkamp; J. de Graaf; A.F.H. Stalenhoef

From the Department of Medicine, Division of General Internal Medicine, University Medical Center Nijmegen, The Netherlands.

Correspondence to J. de Graaf, MD, PhD, Department of Medicine, Division of General Internal Medicine 541, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail j.degraaf{at}aig.umcn.nl

Objective— Insulin resistance is associated with increased triglyceride levels, low high-density lipoprotein cholesterol, small dense low-density lipoprotein (LDL), and increased apolipoprotein B (apoB) levels, all characteristics of familial combined hyperlipidemia (FCH). Therefore, we explored the role of insulin resistance in FCH lipid phenotype expression.

Methods and Results— FCH was defined by traditional diagnostic criteria including plasma total cholesterol or triglyceride levels >90th percentile. Insulin resistance was assessed by the Homeostasis Model Assessment (HOMA) index. In total, 132 subjects with FCH, 350 normolipidemic relatives, and 81 spouses who referenced as controls were studied. FCH subjects were significantly more insulin resistant compared with controls and normolipidemic relatives (HOMA index 2.9 [95% CI, 2.6 to 3.2], 2.2 [95% CI, 2.0 to 2.5], and 2.0 [95% CI, 1.9 to 2.2], respectively), even after correction for sex, age, and body mass index (BMI). The degree of insulin resistance was associated with the lipid phenotype expression, and a change in insulin-resistant state was associated with a change in lipid phenotype expression over 5 years. For any level of insulin resistance and degree of obesity, FCH subjects had increased levels of apoB and more small dense LDL compared with controls.

Conclusion— Insulin resistance is a characteristic feature of FCH, which is not fully explained by their increased BMI and is associated with (change in) lipid phenotype expression. Furthermore, our results support the concept of genetic origin of high apoB and small dense LDL in FCH, which is modulated by insulin resistance and obesity.

FCH subjects are insulin resistant even after correction for obesity, which is dependent on lipid phenotype expression. A change in insulin resistance is associated with a change in lipid phenotype expression in time. Finally, insulin resistance or obesity does not fully account for the increased plasma levels of apoB or high occurrence of small dense LDL in FCH.

Key Words: apolipoprotein B • familial combined hyperlipidemia • insulin resistance • obesity • small dense low-density lipoproteins

This article has been cited by other articles:

				A. L. Garcia-Otin, M. Cofan, M. Junyent, D. Recalde, A. Cenarro, M. Pocovi, E. Ros, and F. Civeira Increased Intestinal Cholesterol Absorption in Autosomal Dominant Hypercholesterolemia and No Mutations in the Low-Density Lipoprotein Receptor or Apolipoprotein B Genes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3667 - 3673. [Abstract] [Full Text] [PDF]

				K. R. Coenen, M. L. Gruen, A. Chait, and A. H. Hasty Diet-Induced Increases in Adiposity, but Not Plasma Lipids, Promote Macrophage Infiltration Into White Adipose Tissue Diabetes, March 1, 2007; 56(3): 564 - 573. [Abstract] [Full Text] [PDF]

				Y. Asato, K. Katsuren, T. Ohshiro, K. Kikawa, T. Shimabukuro, and T. Ohta Relationship Between Lipid Abnormalities and Insulin Resistance in Japanese School Children Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2781 - 2786. [Abstract] [Full Text] [PDF]

				G. M. van der Vleuten, L. J. H. van Tits, M. den Heijer, H. Lemmers, A. F. H. Stalenhoef, and J. de Graaf Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile J. Lipid Res., November 1, 2005; 46(11): 2398 - 2404. [Abstract] [Full Text] [PDF]